Skip to main content
Clinical Trials/IRCT20181019041385N1
IRCT20181019041385N1
Completed
Phase 3

Comparision of the efficacy of pharmacotherapy and combination of pharmacotherapy with transdiagnostic cognitive-behavior therapy on anxiety and depression symptoms in patients with emotional disorders

The university of kurdestan0 sites29 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
The university of kurdestan
Enrollment
29
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
The university of kurdestan

Eligibility Criteria

Inclusion Criteria

  • Anxiety Disorder and Comorbid Depression (According to Psychiatrist)
  • Sanandaj resident
  • No history of substance abuse
  • The desire to participate and not receive any therapeutic intervention, including psychological and medication, at least in the last year

Exclusion Criteria

  • Has personality disorders
  • A history of suicide

Outcomes

Primary Outcomes

Not specified

Similar Trials